back to cluster viewer
cluster path 00110110110
86 words, 16,701 tokens
freq alpha suffix
Words in frequency order
1 | measure | 16,591
|
2 | test-16 | 6
|
3 | preparative-scale | 4
|
4 | test-20 | 4
|
5 | cctas | 3
|
6 | 1.5cm | 2
|
7 | 4-oh-pcb-107 | 2
|
8 | assessor.the | 2
|
9 | carboxyls | 2
|
10 | chelant | 2
|
11 | cortex-muscle | 2
|
12 | crosscheck | 2
|
13 | fnbs | 2
|
14 | fully-fried | 2
|
15 | moderate.there | 2
|
16 | recanalise | 2
|
17 | scale-ms | 2
|
18 | 01/04/11 | 1
|
19 | 09/2007 | 1
|
20 | 09/2008 | 1
|
21 | 100,000/microliter | 1
|
22 | 158-item | 1
|
23 | 22-folds | 1
|
24 | 24l:0d | 1
|
25 | 33-35°c | 1
|
26 | 37-50°c | 1
|
27 | 43.16°c | 1
|
28 | 511oe | 1
|
29 | a20/r10 | 1
|
30 | advice.there | 1
|
31 | assessment.for | 1
|
32 | assessments-that | 1
|
33 | assessors.although | 1
|
34 | assessors.for | 1
|
35 | assessors.forced | 1
|
36 | assessors.topical | 1
|
37 | asthma.there | 1
|
38 | b-lactams | 1
|
39 | bion-m1 | 1
|
40 | bis-ketal | 1
|
41 | candiduria/bacteriuria | 1
|
42 | cefoperazone/sulbouam | 1
|
43 | ct.ef-rt | 1
|
44 | data.our | 1
|
45 | development-classical | 1
|
46 | domains-early | 1
|
47 | em.cystectomy | 1
|
48 | endpoint- | 1
|
49 | female.there | 1
|
50 | fivefolds | 1
|
51 | flurothyl | 1
|
52 | gardrerella | 1
|
53 | histamine/methacholine | 1
|
54 | instrument-nass | 1
|
55 | meansure | 1
|
56 | measurements.there | 1
|
57 | measures-conducted | 1
|
58 | measures-motor | 1
|
59 | modafinil/armodafinil | 1
|
60 | mother-up | 1
|
61 | n-octadecane | 1
|
62 | non-report | 1
|
63 | outcomes-whether | 1
|
64 | outcomesfor | 1
|
65 | outcomewas | 1
|
66 | partners.of | 1
|
67 | pastorilists | 1
|
68 | pelecitus | 1
|
69 | peppertree | 1
|
70 | placebo.otfc | 1
|
71 | re-operate | 1
|
72 | reemerge | 1
|
73 | reported.balanced | 1
|
74 | reporting.several | 1
|
75 | resonancethrombography | 1
|
76 | response-venous | 1
|
77 | scale-acquired | 1
|
78 | self/others | 1
|
79 | setdet | 1
|
80 | thyroma | 1
|
81 | tumorangiognesis | 1
|
82 | twice-after | 1
|
83 | variables-noninvasive | 1
|
84 | variables-radiographic | 1
|
85 | variables.is | 1
|
86 | vbap/vmcp | 1
|
Words in alphabetical order
1 | 01/04/11 | 1
|
2 | 09/2007 | 1
|
3 | 09/2008 | 1
|
4 | 1.5cm | 2
|
5 | 100,000/microliter | 1
|
6 | 158-item | 1
|
7 | 22-folds | 1
|
8 | 24l:0d | 1
|
9 | 33-35°c | 1
|
10 | 37-50°c | 1
|
11 | 4-oh-pcb-107 | 2
|
12 | 43.16°c | 1
|
13 | 511oe | 1
|
14 | a20/r10 | 1
|
15 | advice.there | 1
|
16 | assessment.for | 1
|
17 | assessments-that | 1
|
18 | assessor.the | 2
|
19 | assessors.although | 1
|
20 | assessors.for | 1
|
21 | assessors.forced | 1
|
22 | assessors.topical | 1
|
23 | asthma.there | 1
|
24 | b-lactams | 1
|
25 | bion-m1 | 1
|
26 | bis-ketal | 1
|
27 | candiduria/bacteriuria | 1
|
28 | carboxyls | 2
|
29 | cctas | 3
|
30 | cefoperazone/sulbouam | 1
|
31 | chelant | 2
|
32 | cortex-muscle | 2
|
33 | crosscheck | 2
|
34 | ct.ef-rt | 1
|
35 | data.our | 1
|
36 | development-classical | 1
|
37 | domains-early | 1
|
38 | em.cystectomy | 1
|
39 | endpoint- | 1
|
40 | female.there | 1
|
41 | fivefolds | 1
|
42 | flurothyl | 1
|
43 | fnbs | 2
|
44 | fully-fried | 2
|
45 | gardrerella | 1
|
46 | histamine/methacholine | 1
|
47 | instrument-nass | 1
|
48 | meansure | 1
|
49 | measure | 16,591
|
50 | measurements.there | 1
|
51 | measures-conducted | 1
|
52 | measures-motor | 1
|
53 | modafinil/armodafinil | 1
|
54 | moderate.there | 2
|
55 | mother-up | 1
|
56 | n-octadecane | 1
|
57 | non-report | 1
|
58 | outcomes-whether | 1
|
59 | outcomesfor | 1
|
60 | outcomewas | 1
|
61 | partners.of | 1
|
62 | pastorilists | 1
|
63 | pelecitus | 1
|
64 | peppertree | 1
|
65 | placebo.otfc | 1
|
66 | preparative-scale | 4
|
67 | re-operate | 1
|
68 | recanalise | 2
|
69 | reemerge | 1
|
70 | reported.balanced | 1
|
71 | reporting.several | 1
|
72 | resonancethrombography | 1
|
73 | response-venous | 1
|
74 | scale-acquired | 1
|
75 | scale-ms | 2
|
76 | self/others | 1
|
77 | setdet | 1
|
78 | test-16 | 6
|
79 | test-20 | 4
|
80 | thyroma | 1
|
81 | tumorangiognesis | 1
|
82 | twice-after | 1
|
83 | variables-noninvasive | 1
|
84 | variables-radiographic | 1
|
85 | variables.is | 1
|
86 | vbap/vmcp | 1
|
Words in suffix order
1 | endpoint- | 1
|
2 | a20/r10 | 1
|
3 | test-20 | 4
|
4 | 01/04/11 | 1
|
5 | bion-m1 | 1
|
6 | test-16 | 6
|
7 | 09/2007 | 1
|
8 | 4-oh-pcb-107 | 2
|
9 | 09/2008 | 1
|
10 | candiduria/bacteriuria | 1
|
11 | gardrerella | 1
|
12 | thyroma | 1
|
13 | placebo.otfc | 1
|
14 | variables-radiographic | 1
|
15 | 37-50°c | 1
|
16 | 33-35°c | 1
|
17 | 43.16°c | 1
|
18 | 24l:0d | 1
|
19 | reported.balanced | 1
|
20 | assessors.forced | 1
|
21 | fully-fried | 2
|
22 | scale-acquired | 1
|
23 | measures-conducted | 1
|
24 | peppertree | 1
|
25 | reemerge | 1
|
26 | assessor.the | 2
|
27 | preparative-scale | 4
|
28 | cortex-muscle | 2
|
29 | n-octadecane | 1
|
30 | histamine/methacholine | 1
|
31 | 511oe | 1
|
32 | asthma.there | 1
|
33 | advice.there | 1
|
34 | female.there | 1
|
35 | moderate.there | 2
|
36 | measurements.there | 1
|
37 | measure | 16,591
|
38 | meansure | 1
|
39 | recanalise | 2
|
40 | re-operate | 1
|
41 | variables-noninvasive | 1
|
42 | partners.of | 1
|
43 | assessors.although | 1
|
44 | crosscheck | 2
|
45 | assessors.topical | 1
|
46 | development-classical | 1
|
47 | reporting.several | 1
|
48 | bis-ketal | 1
|
49 | modafinil/armodafinil | 1
|
50 | flurothyl | 1
|
51 | cefoperazone/sulbouam | 1
|
52 | 1.5cm | 2
|
53 | 158-item | 1
|
54 | vbap/vmcp | 1
|
55 | mother-up | 1
|
56 | outcomes-whether | 1
|
57 | twice-after | 1
|
58 | 100,000/microliter | 1
|
59 | assessors.for | 1
|
60 | assessment.for | 1
|
61 | outcomesfor | 1
|
62 | measures-motor | 1
|
63 | data.our | 1
|
64 | cctas | 3
|
65 | outcomewas | 1
|
66 | fnbs | 2
|
67 | 22-folds | 1
|
68 | fivefolds | 1
|
69 | variables.is | 1
|
70 | tumorangiognesis | 1
|
71 | carboxyls | 2
|
72 | scale-ms | 2
|
73 | b-lactams | 1
|
74 | self/others | 1
|
75 | instrument-nass | 1
|
76 | pastorilists | 1
|
77 | response-venous | 1
|
78 | pelecitus | 1
|
79 | assessments-that | 1
|
80 | setdet | 1
|
81 | chelant | 2
|
82 | ct.ef-rt | 1
|
83 | non-report | 1
|
84 | resonancethrombography | 1
|
85 | domains-early | 1
|
86 | em.cystectomy | 1
|